MAXIPIME

This brand name is authorized in Estonia, Hong Kong, Japan, Lithuania, Mexico, South Africa

Active ingredients

The drug MAXIPIME contains one active pharmaceutical ingredient (API):

1 Cefepime dihydrochloride monohydrate
UNII 2A1O4F5N0C - CEFEPIME HYDROCHLORIDE ANHYDROUS

Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases.

Read about Cefepime

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01DE01 Cefepime J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DE Fourth-generation cephalosporins
Discover more medicines within J01DE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1024670
Country: HK Department of Health Drug Office Identifier(s): 39153
Country: JP 医薬品医療機器総合機構 Identifier(s): 6132425D1024, 6132425D2020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1011943
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 128M95
Country: ZA Health Products Regulatory Authority Identifier(s): 28/20.1.1/0722, 28/20.1.1/0723, 28/20.1.1/0724

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.